Dr. Allaway on the increased efficiency of transperineal biopsies
“We need to do a better job sampling the prostate,” says Matthew J. Allaway, MD.
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Matthew J. Allaway, MD. He discusses how his new technology, The PrecisionPoint Transperineal Access System, is used for detecting prostate cancer in patients. Matthew J. Allaway, MD, is the founder and president of Perinealogic and a urologist and managing partner at Urology Associates, Cumberland, Maryland.
Dr. Agarwal on significance of ultra-low PSA levels achieved with apalutamide in mCSPC
January 11th 2024Neeraj Agarwal, MD, discusses an analysis from the phase 3 TITAN trial that explored the correlation between PSA response and survival among patients with metastatic castration-sensitive prostate cancer receiving apalutamide.
